The UK Biometrics As a Service in Healthcare Market was valued at $20.7 Million in 2023 and projected to reach to $55.1 Million by 2028, representing a compound annual growth rate of 21.7%. The UK Biometrics As a Service in Healthcare Market is poised for substantial growth through 2028, driven by NHS modernization initiatives and increasing pressure to implement secure patient identification systems.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The UK Biometrics As a Service in Healthcare Market is valued at $20.7 million in 2023, with a strong projected CAGR of 21.7%, reaching $55.1 million by 2028, significantly outpacing the global average of 20.7%.
The UK's National Health Service is increasingly adopting biometric authentication systems to enhance patient identification accuracy, reduce medical errors, and strengthen data security compliance across NHS trusts and healthcare providers.
UK healthcare organizations face stringent data protection requirements under GDPR and NHS Digital Security Standards, driving investment in secure biometric identification solutions to safeguard patient records and maintain regulatory compliance.
Growing demand for fingerprint, facial recognition, and iris scanning technologies in UK hospitals and clinics is addressing critical needs for accurate patient identification, reducing identity fraud, and improving clinical workflow efficiency.
| Report Metric | Details |
|---|---|
| Base Year | 2023 |
| Fastest Growing Segment | VOICE RECOGNITION (Solution Type) |
| Forecast Period | 2023-2028 |
| Growth Rate | CAGR of 20.7% from 2023 to 2028 |
| Largest Segment | SOFTWARE (Component) |
| Market Size Base Year (Billions) | ~USD 0.43 (2023) |
| Revenue Forecast (Billions) | ~USD 1.1 (2028) |
| Segments Covered | Component, Modality, Solution Type, Application, End User |
5 segment dimensions are covered across the global market.
| Segment | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| AMBULATORY SURGICAL CENTERS | 2.2 | 2.9 | 3.5 | 4.2 | 5.2 | 6.4 | 8 | 9.9 | 23.4 |
| HOSPITALS & CLINICS | 7.1 | 8.3 | 9.9 | 11.9 | 14.3 | 17.3 | 21 | 25.6 | 21 |
| LONG-TERM CARE CENTERS & HOME CARE SETTINGS | 4.2 | 5.1 | 6.1 | 7.4 | 8.9 | 10.9 | 13.3 | 16.4 | 21.8 |
| OTHER END USERS | 4.2 | 4.6 | 5.4 | 6.4 | 7.7 | 9.1 | 11 | 13.2 | 19.4 |
| TOTAL | 17.6 | 20.9 | 24.9 | 30 | 36.1 | 43.8 | 53.3 | 65.2 | 21.2 |
The UK Biometrics As a Service in Healthcare Market was valued at $20.7 million in 2023 and is projected to reach $55.1 million by 2028.
The UK market is growing at a compound annual growth rate (CAGR) of 21.7% from 2023 to 2028, outpacing global market trends.
UK healthcare organizations primarily adopt fingerprint recognition, facial recognition, and iris scanning technologies for patient identification and access control.
GDPR compliance, NHS Digital standards, and data protection regulations are key drivers encouraging UK healthcare providers to implement biometric authentication solutions.
Hospitals, diagnostic centers, telemedicine platforms, and NHS facilities are the primary segments driving demand for Biometrics As a Service solutions in the UK.
This study involved four major activities in estimating the size of biometrics as a service in the healthcare market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the Accreditation Council for Continuing Medical Education (ACCME), Royal College of Physicians and Surgeons of Canada (RCPSC), World Health Organization (WHO), European Accreditation Council for CME (EACCME), Agency for Healthcare Research and Quality (AHRQ), European Union of Medical Specialists (UEMS), Eurostat, The American College of Cardiology (ACC), The American Registry of Radiologic Technologists (ARRT), Expert Interviews, and MarketsandMarkets Analysis.
Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the clinical decision support system market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the clinical decision support system market. The primary sources from the demand side included industry experts, consultants, healthcare providers, hospital administration, and government bodies. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

Tiers are defined based on a company’s total revenue. As of 2022: Tier 1= >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3= <USD 50 million.
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the biometrics as a service in the healthcare market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

To know about the assumptions considered for the study, Request for Free Sample Report

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the provider, payer, and other industries.
Healthcare biometrics refers to the application of biometric technology, such as fingerprint or facial recognition, in the healthcare sector for patient identification, access control, and data security purposes. Biometrics as a service (BaaS) in healthcare involves the delivery of biometric solutions through cloud-based platforms, allowing healthcare organizations to utilize biometric authentication and identification services on a scalable and subscription-based model without the need for extensive in-house infrastructure.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Biometrics As a Service in Healthcare Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report